Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -195.38% | -69.59% | -28.25% |
| Total Depreciation and Amortization | -- | -- | -4.56% | 0.04% | -2.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 657.58% | 760.61% | 635.76% |
| Change in Net Operating Assets | -- | -- | -136.28% | -84.96% | -42.72% |
| Cash from Operations | -- | -- | -951.16% | -132.22% | -26.64% |
| Capital Expenditure | -- | -- | -456.11% | -188.08% | -17.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -717.19% | 97.11% | 98.00% |
| Total Debt Issued | -- | -- | 88.09% | 0.61% | -10.85% |
| Total Debt Repaid | -- | -- | 21.09% | -69.51% | -67.36% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 2,541.71% | -52.09% | -86.20% |
| Foreign Exchange rate Adjustments | -- | -- | 215.71% | -116.73% | 15.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 5,781.04% | -219.30% | -23.87% |